The company jumped into the GLP-1 market last May, offering compounded semaglutide an off-brand version of Ozempic
However, in the case of Ozempic, it is rather clear that the main cause of the shortage is the boom in demand
Shapiro, Elbert Chin, Jiayao Li, Jennifer R
Regardless of the inconclusive scientific findings on GLP-1 alternative supplementation, countless users of these formulas have glowing anecdotal reviews, citing experiences of weight loss, reduced cravings, more energy, and improved digestion
Additionally, the review highlights the STRIDE trial in peripheral artery disease, where Semaglutide improved maximum walking distance in people with T2D and PAD, an effect correlated in part with weight loss
BPC-157 is not an FDA-approved drug, which means it is not available as a retail prescription the way a branded pharmaceutical is